Adjuvia Therapeutics is a biotechnology company located in San Francisco, developing innovative therapies for mitochondrial dysfunction and disease. Founded in 2023, the company is advancing a multi-pronged approach to mitochondrial repair by simultaneously targeting oxidative stress, chronic inflammation, and organ degeneration.

Key Contact